NEWS AND EVENTS

Press Releases

Multi-national biopharmaceutical company demonstrates continued confidence in Cryptzone's secure access technology

September 2, 2013

Cryptzone, the IT security and threat mitigation specialist, today confirmed a renewal support and maintenance contract for AppGate appliances and software, valued at £31k, from a multi-national biopharmaceutical company.

The renewal contract for the US and Europe is part of a broader global deal, in which Cryptzone supports nearly 1,000 global users. Cryptzone AppGate secure access technology from Cryptzone is used for network segmentation and remote access to corporate based applications, such as email.

Einar Lindquist, CEO at Cryptzone, states: "It is particularly gratifying when our long-term clients continue to place their trust in our IT security products and services."

For more information:

Einar Lindquist, CEO, Cryptzone Group AB
einar.lindquist@cryptzone.com
Tel: +46 704-299 839

Beverley Stonehouse, Head of Marketing & Communications, Cryptzone Group AB
pr@cryptzone.com
Tel: +44 1252 419990

About the Cryptzone Group:

The Cryptzone Group is a technology innovator of proactive controls to mitigate IT security risk. Our solutions enable organizations to securely connect, collaborate and comply within the digital workplace, thereby improving document security, access control and compliance auditing capabilities.

Headquartered in Sweden, the company has a presence in the USA, UK, Belgium, Germany and Poland, as well as an extensive partner network with more than 150 global partners. For more information about the company and its solutions, visit www.cryptzone.com.

Cryptzone's share is listed on First North, Sweden, the Nordic alternative market operated by NASDAQ OMX. Certified Adviser is Thenberg & Kinde Fondkommission AB.